-
HOOK Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
HOOKIPA Pharma (HOOK)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
13F holders | Current |
---|---|
Total holders | 53 |
Opened positions | 16 |
Closed positions | 8 |
Increased positions | 12 |
Reduced positions | 9 |
13F shares | Current |
---|---|
Total value | 28.95 bn |
Total shares | 52.61 mm |
Total puts | 4.50 k |
Total calls | 13.40 k |
Total put/call ratio | 0.3 |
Largest owners | Shares | Value |
---|---|---|
Artal | 5.67 mm | $4.99 mm |
Knoll Capital Management | 5.52 mm | $7.23 mm |
FMR | 4.83 mm | $4.25 bn |
EcoR1 Capital | 4.60 mm | $4.04 bn |
Baker Bros. Advisors | 4.43 mm | $3.89 bn |
Armistice Capital | 3.86 mm | $3.39 bn |
GILD Gilead Sciences | 3.76 mm | $6.47 mm |
Redmile | 3.29 mm | $2.89 bn |
Sofinnova Capital Vi FCPR | 3.14 mm | $4.05 mm |
Alyeska Investment | 3.11 mm | $2.74 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
22 Jul 24 | Malte Peters | Common Stock | Grant | Acquire A | No | No | 0 | 108,695 | 0.00 | 108,695 |
22 Jul 24 | Mary Theresa Coelho | Common Stock | Grant | Acquire A | No | No | 0 | 69,875 | 0.00 | 69,875 |
22 Jul 24 | Sean A Cassidy | Stock Option Common Stock | Grant | Acquire A | No | No | 6.44 | 9,800 | 63.11 k | 9,800 |
17 Jun 24 | Mary Theresa Coelho | Stock Option Common Stock | Grant | Acquire A | No | No | 0.71 | 49,000 | 34.79 k | 49,000 |